Glucagonoma MRI

Glucagonoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Glucagonoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Glucagonoma MRI On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Glucagonoma MRI All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Glucagonoma MRI
CDC on Glucagonoma MRI
Glucagonoma MRI in the news
Blogs on Glucagonoma MRI
Directions to Hospitals Treating Glucagonoma
Risk calculators and risk factors for Glucagonoma MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2], Mohammed Abdelwahed M.D[3]

Overview

Abdominal MRI is helpful in the diagnosis of glucagonoma. On abdominal MRI, glucagonoma is characterized by a mass which is hypo-intense on T1-weighted MRI and hyper-intense on T2-weighted MRI. MRI is preferred over contrast-enhanced CT or somatostatin receptor scintigraphy for assessing metastasis.

MRI

• Findings on abdominal MRI suggestive of glucagonoma include:
  • T1: low signal intensity
  • T2: high signal intensity
• MRI is preferred over contrast-enhanced CT or somatostatin receptor scintigraphy for assessing metastasis.